Kyprolis 60 MG vials
Ended Awarded
- Contract number
- SPE2DB25FFBV0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,991
Award facts
- Contract value 100% obligated
- $17,990.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,990.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Kyprolis 60 mg vials, with an ultimate completion date of August 27, 2025. This competitively awarded contract, issued on August 6, 2025, carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order functions as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, a $999,999,999.00 prime contract valued through December 2026 that supports global pharmaceutical supply requirements for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor specializing in brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Kyprolis is a specialty oncology medication used in the treatment of multiple myeloma, reflecting the company's role in supplying critical pharmaceutical commodities to support military and veteran healthcare systems. The DLA Troop Support Medical IDC enables AmerisourceBergen to deliver a comprehensive range of pharmaceutical products to multiple federal customers, including the Defense Health Agency and U.S. Coast Guard, through a flexible contracting mechanism designed to meet global medical supply needs.
Quick answers
Who was awarded contract SPE2DB25FFBV0?
SPE2DB25FFBV0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FFBV0 worth?
The government has obligated $17,991 on SPE2DB25FFBV0.
Is contract SPE2DB25FFBV0 an order under another contract?
Yes. SPE2DB25FFBV0 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFBV0 competed?
The extent of competition for SPE2DB25FFBV0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award